Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.

類似資料

• Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.
  著者:: Ravaud, A., 等
  出版事項: (1994)
• A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
  著者:: Jayson, G. C., 等
  出版事項: (1998)
• Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanoma.
  著者:: Kruit, W. H., 等
  出版事項: (1995)
• Rapid deterioration in quality of life during interleukin-2- and α-interferon-based home therapy of renal cell carcinoma is associated with a good outcome
  著者:: Atzpodien, J, 等
  出版事項: (2003)
• Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
  著者:: Pichert, G., 等
  出版事項: (1990)